NCT00560300View on ClinicalTrials.gov

Regulation of Bone Formation in Renal Osteodystrophy

PHASE2CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

November 30, 2000

Study Completion Date

November 30, 2006

Conditions
Secondary HyperparathyroidismRenal Osteodystrophy
Interventions
DRUG

1 alpha D2

Vitamin D sterol

DRUG

1,25 dihydroxy vitamin D3

Active vitamin D sterol

DRUG

Sevelamer HCl

Phosphate binder

DRUG

Calcium Carbonate

Phosphate binder

All Listed Sponsors
lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00560300 - Regulation of Bone Formation in Renal Osteodystrophy | Biotech Hunter | Biotech Hunter